Haoxi Health Technology Limited
HAO
$1.21
-$0.0198-1.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.92% | 1.92% | 31.20% | 31.20% | 156.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.92% | 1.92% | 31.20% | 31.20% | 156.52% |
| Cost of Revenue | 5.25% | 5.25% | 32.32% | 32.32% | 164.48% |
| Gross Profit | -60.01% | -60.01% | 16.31% | 16.31% | 64.53% |
| SG&A Expenses | 53.38% | 53.38% | 1.11% | 1.11% | 64.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.16% | 6.16% | 31.33% | 31.33% | 161.66% |
| Operating Income | -115.57% | -115.57% | 27.85% | 27.85% | 66.07% |
| Income Before Tax | -99.75% | -99.75% | 32.74% | 32.74% | 64.65% |
| Income Tax Expenses | 486.50% | 486.50% | 122.25% | 122.25% | 2.56% |
| Earnings from Continuing Operations | -130.60% | -130.60% | 1.64% | 1.64% | 70.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.60% | -130.60% | 1.64% | 1.64% | 70.07% |
| EBIT | -115.57% | -115.57% | 27.85% | 27.85% | 66.07% |
| EBITDA | -114.19% | -114.19% | 27.39% | 27.67% | 67.88% |
| EPS Basic | -119.89% | -119.89% | -4.34% | -4.34% | 46.37% |
| Normalized Basic EPS | -99.81% | -99.81% | 24.96% | 24.96% | 41.68% |
| EPS Diluted | -120.31% | -120.31% | -3.63% | -3.63% | 46.37% |
| Normalized Diluted EPS | -99.81% | -99.81% | 24.96% | 24.96% | 41.68% |
| Average Basic Shares Outstanding | 53.90% | 53.90% | 6.26% | 6.26% | 16.19% |
| Average Diluted Shares Outstanding | 53.90% | 53.90% | 6.26% | 6.26% | 16.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |